[Federal Register Volume 67, Number 92 (Monday, May 13, 2002)]
[Notices]
[Page 32055]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 02-11787]



[[Page 32055]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Request for Nominations for Voting Members on Public Advisory 
Committee; Veterinary Medicine Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for voting members to serve on the Veterinary Medicine 
Advisory Committee (VMAC) in one of the following specialty areas: 
Pharmacology, Minor Species/Minor Use Veterinary Medicine, and 
pathology. Nominations for the VMAC chairperson are also being 
solicited. Information regarding the committee can be found on the CVM 
home page at http://www.fda.gov/cvm/index/vmac/vmactoc.htm.
    FDA has a special interest in ensuring that women, minority groups, 
and the physically challenged are adequately represented on advisory 
committees and, therefore, encourages nominations of qualified 
candidates from these groups.

DATES: FDA is seeking nominations for voting members, as well as, 
nominations for the VMAC chairperson by May 15, 2002. Because scheduled 
vacancies occur on various dates throughout each subsequent year, no 
cutoff date for those specialty areas has been established.

ADDRESSES: All nominations and curricula vitae should be sent to the 
appropriate contact person in the FOR FURTHER INFORMATION CONTACT 
section of this document.

FOR FURTHER INFORMATION CONTACT:   
    Regarding nominations except for consumer representatives: Aleta 
Sindelar, Center for Veterinary Medicine, Food and Drug Administration, 
7519 Standish Pl., Rockville, MD 20855, 301-827-4515, e-mail: 
asindela@cvm.fda.gov.
    Regarding nominations for consumer representatives: Linda Sherman, 
Advisory Committee Oversight and Management Staff (HF-4), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857.

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting 
members to serve on the committee. The function of the VMAC is to 
advise the Commissioner of Food and Drugs (the Commissioner) in 
discharging their responsibilities as they relate to assuring safe and 
effective drugs, feeds and feed additives, and devices for animal use, 
and, as required, any other product for which FDA has regulatory 
responsibility. The committee reviews and evaluates available data 
concerning the safety and effectiveness of marketed and investigational 
new animal drugs, feeds, and devices for use in the treatment and 
prevention of animal diseases and increased animal production, and 
makes appropriate recommendations to the Commissioner regarding 
scientific issues and regulatory policies.

Qualifications

    Persons nominated for membership on the committee shall have 
adequately diversified experience that is appropriate to the work of 
the committee in such fields as companion animal medicine, food animal 
medicine, avian medicine, microbiology, biometrics, toxicology, 
pathology, pharmacology, animal science, public health/epidemiology, 
Minor Species/Minor Use Veterinary Medicine, and chemistry. The 
specialized training and experience necessary to qualify the nominee as 
an expert suitable for appointment is subject to review, but may 
include experience in medical practice, teaching, and/or research 
relevant to the field of activity of the committee. The term of office 
is 4 years. The committee currently has three vacancies and is 
requesting nominations for voting members to serve on one of the 
following specialty areas: Pharmacology, Minor Species/Minor Use 
Veterinary Medicine, and pathology. Nominations for the VMAC 
chairperson are also being solicited.

Nomination Procedures

    Any interested person may nominate one or more qualified persons 
for membership on one or more of the advisory committees. Self-
nominations are also accepted. Nominations shall include the name of 
the committee, a complete curriculum vitae of each nominee, current 
business address and telephone number, and shall state that the nominee 
is aware of the nomination, is willing to serve as a member, and 
appears to have no conflict of interest that would preclude membership. 
FDA will ask the potential candidates to provide detailed information 
concerning such matters as financial holdings, employment, and research 
grants and/or contracts to permit evaluation of possible sources of 
conflict of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14 relating to advisory committees.

    Dated: May 2, 2002.
Bonnie Malkin,
Acting Senior Associate Commissioner for Communications and Constituent 
Relations.
[FR Doc. 02-11787 Filed 5-10-02; 8:45 am]
BILLING CODE 4160-01-S